Compare STKE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STKE | CCEL |
|---|---|---|
| Founded | 2002 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Managed Health Care |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 32.7M |
| IPO Year | N/A | 2022 |
| Metric | STKE | CCEL |
|---|---|---|
| Price | $1.31 | $3.30 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 157.7K | 12.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.41% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | $15.56 | $0.30 |
| Revenue Next Year | $44.24 | N/A |
| P/E Ratio | ★ N/A | $20.00 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $1.18 | $3.10 |
| 52 Week High | $7.75 | $7.70 |
| Indicator | STKE | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 42.04 |
| Support Level | $1.18 | $3.33 |
| Resistance Level | $2.80 | $3.57 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 40.00 | 35.82 |
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.